Cumberland Pharmaceuticals (CPIX) Research & Development (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Research & Development of $5.1 million for Q1 2026, down 18.42% sequentially from $6.2 million in Q4 2025, and up 19.68% YoY from $4.2 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Research & Development (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Research & Development for 17 years, with the latest figure at $5.1 million in Q1 2026.
- Quarterly Research & Development rose 19.68% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.9 million (down 14.41% YoY) and the FY2025 annual result came in at $19.1 million, up 12.19% from the prior year.
- Research & Development fell to $5.1 million in Q1 2026 per CPIX's latest filing, from $6.2 million in the prior quarter.
- Over five years, Research & Development peaked at $13.5 million in Q4 2024 and troughed at $1.1 million in Q2 2023.
- A 5-year average of $4.3 million and a median of $4.2 million in 2025 frame the typical range for Research & Development.
- The widest YoY moves for Research & Development: up 271.03% in 2024, down 72.46% in 2024.
- Over 5 years, Research & Development stood at $11.4 million in 2022, then plunged by 58.17% to $4.8 million in 2023, then surged by 183.65% to $13.5 million in 2024, then sank by 54.01% to $6.2 million in 2025, then retreated by 18.42% to $5.1 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $5.1 million, $6.2 million, and $4.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 970.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -1.05 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 146.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 248.30 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 326.70 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 92.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 116.41 Mn | 112.54 Mn | - | 772,162.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 772,162.00 |
| Mar 31, 2026 | 5.06 Mn |
| Dec 31, 2025 | 6.21 Mn |
| Sep 30, 2025 | 4.43 Mn |
| Jun 30, 2025 | 4.22 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Dec 31, 2024 | 13.50 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 4.25 Mn |
| Mar 31, 2024 | 1.16 Mn |
| Dec 31, 2023 | 4.76 Mn |
| Sep 30, 2023 | 4.74 Mn |
| Jun 30, 2023 | 1.15 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 11.38 Mn |
| Sep 30, 2022 | 1.71 Mn |
| Jun 30, 2022 | 1.82 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 10.94 Mn |
| Sep 30, 2021 | 3.80 Mn |